Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Celsion Corporation    CLSN

CELSION CORPORATION

(CLSN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about CELSION CORPORATION
11/16CELSION CORPORATION : Reports Third Quarter 2020 Financial Results and Provides ..
AQ
11/16Celsion Corporation Reports Third Quarter 2020 Financial Results and Provides..
GL
11/13CLSN SHAREHOLDER ALERT : Bronstein, Gewirtz & Grossman, LLC Notifies Celsion Cor..
BU
11/09CELSION CORPORATION : to Hold Third Quarter 2020 Financial Results and Business ..
AQ
11/09Celsion Corporation to Hold Third Quarter 2020 Financial Results and Business..
GL
11/07CELSION : ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Celsion Corporation Investors ..
BU
11/03SHAREHOLDER ACTION REMINDER : The Schall Law Firm Announces the Filing of a Clas..
BU
11/02SHAREHOLDER ACTION ALERT : The Schall Law Firm Announces the Filing of a Class A..
BU
11/02CELSION : ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Act..
BU
10/30CELSION ALERT : Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsui..
BU
10/12CELSION CORPORATION : Issues Letter to Stockholders
AQ
10/12Celsion Corporation Issues Letter to Stockholders
GL
09/08CELSION : Announces Common Stock Purchase Agreement with Lincoln Park Capital an..
AQ
09/08Celsion Announces Common Stock Purchase Agreement with Lincoln Park Capital a..
GL
09/02Celsion Corporation Restructures its Strategic Loan Facility
GL
08/14Celsion Corporation Reports Second Quarter 2020 Financial Results and Provide..
GL
08/07Celsion Corporation to Hold Second Quarter 2020 Financial Results and Busines..
GL
08/04Celsion Corporation to Continue Following Patients in Phase III OPTIMA Study ..
GL
07/27Celsion Corporation Initiates Phase II OVATION 2 Study of GEN-1 in Advanced O..
GL
07/14CELSION CORPORATION TO HOLD CONFEREN : 00 a.m. Eastern Time
GL
07/13Celsion Corporation Receives Recommendation from Independent Data Monitoring ..
GL
06/25CELSION : Affirms July Timing for Second Interim Analysis of the Phase III OPTIM..
AQ
06/24Celsion Corporation Announces Closing of Public Offering of Common Stock
GL
06/22Celsion Corporation Announces Pricing of $10 Million Underwritten Offering of..
GL
05/29Celsion Reports Data Safety Monitoring Board Recommendation to Proceed to Ph..
GL
05/15Celsion Corporation Reports First Quarter 2020 Financial Results and Provides..
GL
05/08Celsion Corporation to Hold First Quarter 2020 Financial Results Conference C..
GL
04/23Celsion Receives $2.5 Million in Non-Dilutive Funding from the Sale of its Ne..
GL
04/15Celsion Reports that Sufficient Events Have Been Reached for the Second Inter..
GL
03/26Celsion's OVATION 1 Study with GEN-1 in Ovarian Cancer Shows Strong Progressi..
GL
03/25Celsion Corporation Reports 2019 Financial Results and Provides Business Upda..
GL
03/23Celsion's GEN-1 Immunotherapy Receives Orphan Drug Designation from the Europ..
GL
03/19Celsion Corporation to Hold Year-End 2019 Financial Results Conference Call o..
GL
03/19Celsion Announces Highly Encouraging Initial Clinical Results from the Phase ..
GL
03/03Celsion CEO Issues Letter to Stockholders
GL
02/28Celsion Corporation Prices $4.8 Million Registered Direct Offering
GL
02/06Celsion Corporation Announces DSMB has Confirmed Initial Safety of Weekly GEN..
GL
02/04Principal Investigator Professor Riccardo Lencioni Presents Celsion ThermoDox..
GL
2019Celsion's New Subsidiary in China to Serve as Beachhead for Commercializing T..
GL
2019Celsion Receives $2.0 Million Allocation Through the New Jersey Technology Bu..
GL
2019Celsion Corporation Reports Third Quarter 2019 Financial Results and Provides..
GL
2019Celsion Announces Publication of Research on Fluorescence Imaging of ThermoDo..
GL
2019Celsion Corporation to Hold Third Quarter 2019 Financial Results Conference C..
GL
2019Celsion Announces DSMB Recommendation to Continue GEN-1 at 100mg/m² Dose to C..
GL
2019CELSION : Reports Unanimous Independent Data Monitoring Committee Recommendation..
PU
2019Celsion Reports Unanimous Independent Data Monitoring Committee Recommendatio..
GL
2019Celsion Strengthens Its 2019 Balance Sheet with the Approval of Its Applicati..
GL
2019Celsion to Present at the Chardan 3rd Annual Genetic Medicines Conference
GL
2019Celsion Co-sponsors Hepatocellular Carcinoma Symposium at the International L..
GL
2019Celsion Announces Publication of Findings from Single-Site Study in China of ..
GL
2019Celsion Corporation Reports Second Quarter 2019 Financial Results and Provide..
GL
2019Celsion Announces Publication of Results of National Institutes of Health (NI..
GL
2019Celsion's GEN-1 Immunotherapy Highlighted in Oppenheimer's Expert Call on Ova..
GL
2019Celsion Corporation to Hold Second Quarter 2019 Financial Results Conference ..
GL
2019Celsion Announces Data Lock for First Interim Analysis in OPTIMA Phase III St..
GL
2019Celsion Announces IRB Approval to Begin a Clinical Study of ThermoDox® Plus H..
GL
2019Celsion Corporation Reports First Quarter 2019 Financial Results and Provides..
GL
2019Celsion Corporation to Participate in Two Investor Conferences in May 2019
GL
2019Celsion Corporation to Hold Year-End 2018 Financial Results Conference Call o..
GL
2019Celsion Announces GEN-1 Data Presentation at ASCO-SITC Clinical Immuno-Oncolo..
GL
2019CELSION : Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PU
2019Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635..
GL
2019Celsion Corporation to Present at NobleConXV – Noble Capital Markets' 1..
GL
2018Celsion Receives $11.1 Million Allocation Through the New Jersey Technology B..
GL
2018Celsion Corporation Reports Third Quarter 2018 Financial Results and Provides..
GL
2018Celsion Corporation to Hold Third Quarter 2018 Financial Results Conference C..
GL
2018Celsion Announces Progression-Free Survival Data From GEN-1 Phase I Immuno-On..
GL
2018Celsion Announces Publication Highlighting the Potential of Celsion's Gene-Me..
GL
2018Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(..
GL
2018CELSION : Appoints Marianne Lambertson as Vice President of Communications and I..
PU
2018Celsion Appoints Marianne Lambertson as Vice President of Communications and..
GL
2018Celsion Strengthens Its Balance Sheet with the Approval of Its Application to..
GL
2018Celsion Corporation Reports Second Quarter 2018 Financial Results and Provide..
GL
2018Celsion Corporation Announces Strategic Loan Facility
GL
2018Celsion Corporation Reports First Quarter 2018 Financial Results and Provides..
GL
1  2Next
Upcoming event on CELSION CORPORATION